Carlsmed (CARL) Income from Continuing Operations (2024 - 2026)

Carlsmed has reported Income from Continuing Operations for 3 years, with the latest figure at 8696000.0 in Q1 2026.

• For the quarter ending Q1 2026, Income from Continuing Operations fell 52.67% year-over-year to 8696000.0; the trailing twelve-month figure through Mar 2026 stood at 32306000.0 (down 32.61% YoY), and the FY2025 full-year result was 29306000.0, down 21.54% from the prior year.
• Income from Continuing Operations for Q1 2026 stood at 8696000.0, down from 8620000.0 in the prior quarter.
• The five-year high for Income from Continuing Operations was 4665000.0 in Q4 2024, with the low at 8696000.0 in Q1 2026.
• Historically, Income from Continuing Operations has averaged 7083500.0 across 3 years, with a median of 7157000.0 in 2024.
• The largest YoY upside for Income from Continuing Operations was 5.04% in 2025 against a maximum downside of 84.78% in 2025.
• Carlsmed's Income from Continuing Operations stood at 4665000.0 in 2024, then tumbled by 84.78% to 8620000.0 in 2025, then decreased by 0.88% to 8696000.0 in 2026.
• The last three Income from Continuing Operations figures came in at 8696000.0 (Q1 2026), 8620000.0 (Q4 2025), and 8461000.0 (Q3 2025), per Business Quant data.